Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
Stock. Additional stock would be great incentive.
Quelles sont les meilleures choses à propos de votre équipe?
My team works hard, is dedicated and supportive of one another.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
The team is nimble and willing to take swift action with matters that affect business.
Qu’est-ce qui vous rend le plus heureux au travail?
It’s fulfilling to pull through initiatives and projects successfully. It’s also nice to feel appreciated or recognition for succe
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Executive team is supportive and generally willing to take swift action when needed. Innovation and urgency enable a healthy nimble environment.
Other Employee Reviews for Karyopharm Therapeutics
×